Cargando…

Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor

OBJECTIVE: To retrospectively determine whether magnetic resonance imaging (MRI) findings can help differentiate a juxtaglomerular cell tumor (JCT) from clear cell renal cell carcinoma (ccRCC). MATERIALS AND METHODS: Eight patients with JCTs and 24 patients with pathologically proven ccRCC were incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Suhai, Guo, Aitao, Wang, Haiyi, Ma, Lu, Xie, Zongyu, Li, Jinglong, Tonge, Xinyuan, Ye, Huiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736060/
https://www.ncbi.nlm.nih.gov/pubmed/26900492
http://dx.doi.org/10.4103/2156-7514.172976
_version_ 1782413201093165056
author Kang, Suhai
Guo, Aitao
Wang, Haiyi
Ma, Lu
Xie, Zongyu
Li, Jinglong
Tonge, Xinyuan
Ye, Huiyi
author_facet Kang, Suhai
Guo, Aitao
Wang, Haiyi
Ma, Lu
Xie, Zongyu
Li, Jinglong
Tonge, Xinyuan
Ye, Huiyi
author_sort Kang, Suhai
collection PubMed
description OBJECTIVE: To retrospectively determine whether magnetic resonance imaging (MRI) findings can help differentiate a juxtaglomerular cell tumor (JCT) from clear cell renal cell carcinoma (ccRCC). MATERIALS AND METHODS: Eight patients with JCTs and 24 patients with pathologically proven ccRCC were included for image analysis. All patients underwent unenhanced MRI and dynamic contrast-enhanced MRI. Fat-suppressed T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), in- and opposed-phase imaging, and fat-suppressed preliver acquisitions with volume acceleration sequences were performed before enhancement. After the administration of contrast, dynamic imaging was performed in the corticomedullary, nephrographic, and excretory phases. Student's t-test, t′-test, Chi-square test, and nonparametric Kruskal–Wallis H-test were used to determine the significance of the difference between the two groups. The sensitivity and specificity of the MRI findings were calculated. RESULTS: In patients with a JCT, a cystic part of the lesion of <10%, isointensity or mild hyperintensity on T2WI, heterogeneous hyperintensity on DWI, less signal drop (<10%) in in- and opposed-phase imaging, and a degree of enhancement <200% in the corticomedullary phase showed statistically significant differences compared with those of ccRCC (P < 0.05). After combining a lower apparent diffusion coefficient (ADC) value (heterogeneous hyperintensity) on DWI and a degree of enhancement <200% in the corticomedullary phase using a parallel test, the sensitivity and specificity were 90.9% and 91.7%, respectively. CONCLUSIONS: Isointensity or mild hyperintensity on T2WI, a lower ADC value (heterogeneous hyperintensity) on DWI, and a degree of enhancement <200% in the corticomedullary phase are the major MRI findings for JCTs, combined with relative clinical manifestations and excluding other renal masses. A main solid tumor, less signal drop (<10%) in in- and opposed-phase imaging, and a less-washout pattern of <10% in the delayed phase are secondary MRI findings for JCTs.
format Online
Article
Text
id pubmed-4736060
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47360602016-02-19 Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor Kang, Suhai Guo, Aitao Wang, Haiyi Ma, Lu Xie, Zongyu Li, Jinglong Tonge, Xinyuan Ye, Huiyi J Clin Imaging Sci Original Article OBJECTIVE: To retrospectively determine whether magnetic resonance imaging (MRI) findings can help differentiate a juxtaglomerular cell tumor (JCT) from clear cell renal cell carcinoma (ccRCC). MATERIALS AND METHODS: Eight patients with JCTs and 24 patients with pathologically proven ccRCC were included for image analysis. All patients underwent unenhanced MRI and dynamic contrast-enhanced MRI. Fat-suppressed T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), in- and opposed-phase imaging, and fat-suppressed preliver acquisitions with volume acceleration sequences were performed before enhancement. After the administration of contrast, dynamic imaging was performed in the corticomedullary, nephrographic, and excretory phases. Student's t-test, t′-test, Chi-square test, and nonparametric Kruskal–Wallis H-test were used to determine the significance of the difference between the two groups. The sensitivity and specificity of the MRI findings were calculated. RESULTS: In patients with a JCT, a cystic part of the lesion of <10%, isointensity or mild hyperintensity on T2WI, heterogeneous hyperintensity on DWI, less signal drop (<10%) in in- and opposed-phase imaging, and a degree of enhancement <200% in the corticomedullary phase showed statistically significant differences compared with those of ccRCC (P < 0.05). After combining a lower apparent diffusion coefficient (ADC) value (heterogeneous hyperintensity) on DWI and a degree of enhancement <200% in the corticomedullary phase using a parallel test, the sensitivity and specificity were 90.9% and 91.7%, respectively. CONCLUSIONS: Isointensity or mild hyperintensity on T2WI, a lower ADC value (heterogeneous hyperintensity) on DWI, and a degree of enhancement <200% in the corticomedullary phase are the major MRI findings for JCTs, combined with relative clinical manifestations and excluding other renal masses. A main solid tumor, less signal drop (<10%) in in- and opposed-phase imaging, and a less-washout pattern of <10% in the delayed phase are secondary MRI findings for JCTs. Medknow Publications & Media Pvt Ltd 2015-12-31 /pmc/articles/PMC4736060/ /pubmed/26900492 http://dx.doi.org/10.4103/2156-7514.172976 Text en Copyright: © 2015 Journal of Clinical Imaging Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kang, Suhai
Guo, Aitao
Wang, Haiyi
Ma, Lu
Xie, Zongyu
Li, Jinglong
Tonge, Xinyuan
Ye, Huiyi
Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title_full Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title_fullStr Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title_full_unstemmed Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title_short Magnetic Resonance Imaging Features of a Juxtaglomerular Cell Tumor
title_sort magnetic resonance imaging features of a juxtaglomerular cell tumor
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736060/
https://www.ncbi.nlm.nih.gov/pubmed/26900492
http://dx.doi.org/10.4103/2156-7514.172976
work_keys_str_mv AT kangsuhai magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT guoaitao magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT wanghaiyi magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT malu magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT xiezongyu magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT lijinglong magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT tongexinyuan magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor
AT yehuiyi magneticresonanceimagingfeaturesofajuxtaglomerularcelltumor